RxSight (RXST) Revenue & Revenue Breakdown
RxSight Revenue Highlights
Latest Revenue (Y)
$139.93M
Latest Revenue (Q)
$40.21M
Main Segment (Y)
RxLAL
Main Geography (Y)
L D D
RxSight Revenue by Period
RxSight Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $139.93M | 57.09% |
| 2023-12-31 | $89.08M | 81.77% |
| 2022-12-31 | $49.01M | 116.90% |
| 2021-12-31 | $22.59M | 53.92% |
| 2020-12-31 | $14.68M | 554.98% |
| 2019-12-31 | $2.24M | - |
RxSight generated $139.93M in revenue during NA 2024, up 57.09% compared to the previous quarter, and up 6243.95% compared to the same period a year ago.
RxSight Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $40.21M | -11.44% |
| 2024-09-30 | $45.41M | 30.16% |
| 2024-06-30 | $34.89M | 18.21% |
| 2024-03-31 | $29.51M | 3.26% |
| 2023-12-31 | $28.58M | -6.81% |
| 2023-09-30 | $30.67M | 47.37% |
| 2023-06-30 | $20.81M | 18.99% |
| 2023-03-31 | $17.49M | 8.71% |
| 2022-12-31 | $16.09M | 27.53% |
| 2022-09-30 | $12.62M | 11.05% |
| 2022-06-30 | $11.36M | 27.04% |
| 2022-03-31 | $8.94M | 6.11% |
| 2021-12-31 | $8.43M | 45.64% |
| 2021-09-30 | $5.79M | 18.15% |
| 2021-06-30 | $4.90M | 40.56% |
| 2021-03-31 | $3.48M | -29.10% |
| 2020-12-31 | $4.91M | 17.84% |
| 2020-09-30 | $4.17M | 54.10% |
| 2020-06-30 | $2.71M | -6.30% |
| 2020-03-31 | $2.89M | - |
RxSight generated $40.21M in revenue during Q4 2024, up -11.44% compared to the previous quarter, and up 131.13% compared to the same period a year ago.
RxSight Revenue Breakdown
RxSight Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 21 |
|---|---|---|
| RxLAL | $96.50M | - |
| Service Warranty Service Contracts And Accessories | $3.73M | $656.00K |
| L D D | $39.70M | $13.77M |
| L A L | - | $8.16M |
RxSight's latest annual revenue breakdown by segment (product or service), as of Dec 24: RxLAL (68.96%), L D D (28.37%), and Service Warranty Service Contracts And Accessories (2.66%).
Quarterly Revenue by Product
| Product/Service | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Jun 23 | Mar 23 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L D D | $9.39M | $10.67M | $10.13M | $10.19M | $8.71M | $7.72M | $6.47M | $5.69M | $5.68M | $4.57M | $5.31M | $3.66M | $2.96M |
| Service Warranty Service Contracts And Accessories | $1.32M | $1.02M | $955.00K | $870.00K | $882.00K | $679.00K | $619.00K | $401.00K | $328.00K | $268.00K | $216.00K | $181.00K | $140.00K |
| RxLAL | - | - | - | - | - | - | - | - | - | $4.11M | $1.94M | - | - |
| L A L | - | - | - | - | - | - | - | - | - | - | - | - | $1.79M |
RxSight's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: L D D (87.68%), and Service Warranty Service Contracts And Accessories (12.32%).
RxSight Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 |
|---|---|
| L A L | $8.16M |
| Service Warranty Service Contracts And Accessories | $656.00K |
| L D D | $13.77M |
RxSight's latest annual revenue breakdown by geography, as of Dec 21: L D D (60.97%), L A L (36.13%), and Service Warranty Service Contracts And Accessories (2.90%).
RxSight Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VREX | Varex Imaging | $811.00M | $199.80M |
| FNA | Paragon 28 | $256.18M | $61.02M |
| TMCI | Treace Medical Concepts | $209.36M | $68.71M |
| KIDS | OrthoPediatrics | $204.73M | $52.67M |
| AXGN | AxoGen | $187.34M | $49.41M |
| SIBN | SI-BONE | $167.18M | $49.00M |
| RXST | RxSight | $139.93M | $40.21M |
| LUNG | Pulmonx | $83.79M | $22.54M |
| NPCE | NeuroPace | $79.91M | $21.47M |
| SGHT | Sight Sciences | $79.87M | $19.07M |
| IRMD | IRadimed | $73.24M | $19.51M |
| CVRX | CVRx | $51.29M | $15.34M |
| APYX | Apyx Medical | $48.10M | $14.22M |
| SSKN | STRATA Skin Sciences | $33.56M | $8.44M |
| OFIX | Orthofix Medical | - | $215.66M |